Okla. Admin. Code § 310:395-5-13

Current through Vol. 42, No. 4, November 1, 2024
Section 310:395-5-13 - Formulary
(a) A Licensed Midwife shall not administer a prescription drug to a Client other than as provided in this section or as ordered by a licensed prescriber for the benefit of the mother or Newborn:
(1) Oxygen for fetal or maternal distress and infant resuscitation;
(2) Local anesthetic (topical, intramuscular, or subcutaneous) for the purpose of postpartum repair of tears, lacerations, or episiotomy (no controlled substances);
(3) Rh immunoglobulin;
(4) Antibiotics for GBS prophylaxis per CDC guidelines;
(5) Vitamin K, for control of bleeding in the Newborn;
(6) Ophthalmic preparations for Newborn eye care;
(7) Epipen (0.3 mg) or generic equivalent for allergic reactions;
(8) Antihemorrhagic medications only permitted for postpartum control of maternal hemorrhage limited to oxytocin, hemabate, misoprostol, and methergine;
(9) Resuscitation supplies and equipment (this does not include the use of intubation equipment);
(10) Any supplies or equipment necessary to administer the above;
(11) Pediatric dose of the Hepatitis B vaccine; and
(12) IV fluids for medication administration, dehydration, or treatment of hypovolemia while awaiting EMS.
(b) As specified in 59 O.S § 3040.4, a Licensed Midwife may lawfully obtain, transport, administer, and have possession of adequate quantities of the above-named medications and the equipment normally required for administration. Each use of medication, lot number, and expiration date shall be recorded by the Licensed Midwife in the Client's chart.
(c) Medication listed in this section shall be stored as directed by the manufacturer and shall not be administered to any person after the expiration date listed.

Okla. Admin. Code § 310:395-5-13

Adopted by Oklahoma Register, Volume 38, Issue 06, December 1, 2020, eff. 11/2/2020
Adopted by Oklahoma Register, Volume 38, Issue 12, March 1, 2021, eff. 2/2/2021
Adopted by Oklahoma Register, Volume 38, Issue 24, September 1, 2021, eff. 9/11/2021